FR07C0023I2 - DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18 - Google Patents

DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18

Info

Publication number
FR07C0023I2
FR07C0023I2 FR07C0023C FR07C0023C FR07C0023I2 FR 07C0023 I2 FR07C0023 I2 FR 07C0023I2 FR 07C0023 C FR07C0023 C FR 07C0023C FR 07C0023 C FR07C0023 C FR 07C0023C FR 07C0023 I2 FR07C0023 I2 FR 07C0023I2
Authority
FR
France
Prior art keywords
dna encoding
virus type
encoding human
papilloma virus
human papilloma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR07C0023C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR07C0023(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/409,122 external-priority patent/US5820870A/en
Priority claimed from US08/408,669 external-priority patent/US5840306A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR07C0023I1 publication Critical patent/FR07C0023I1/fr
Application granted granted Critical
Publication of FR07C0023I2 publication Critical patent/FR07C0023I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR07C0023C 1995-03-22 2007-03-20 DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18 Active FR07C0023I2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/409,122 US5820870A (en) 1995-03-22 1995-03-22 Recombinant human papillomavirus type 18 vaccine
US08/408,669 US5840306A (en) 1995-03-22 1995-03-22 DNA encoding human papillomavirus type 18
PCT/US1996/003649 WO1996029413A2 (en) 1995-03-22 1996-03-18 Dna encoding human papilloma virus type 18

Publications (2)

Publication Number Publication Date
FR07C0023I1 FR07C0023I1 (en) 2007-04-27
FR07C0023I2 true FR07C0023I2 (en) 2012-08-03

Family

ID=27020342

Family Applications (1)

Application Number Title Priority Date Filing Date
FR07C0023C Active FR07C0023I2 (en) 1995-03-22 2007-03-20 DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18

Country Status (22)

Country Link
EP (2) EP0817851B9 (en)
JP (1) JPH11502704A (en)
KR (1) KR100430698B1 (en)
CN (1) CN1100876C (en)
AT (1) ATE259879T1 (en)
AU (1) AU714533B2 (en)
CA (1) CA2215834C (en)
CZ (1) CZ291242B6 (en)
DE (4) DE69631586T9 (en)
DK (1) DK0817851T5 (en)
EA (1) EA001092B1 (en)
ES (1) ES2213772T3 (en)
FR (1) FR07C0023I2 (en)
HU (1) HU223761B1 (en)
IL (1) IL117459A (en)
NL (3) NL300272I1 (en)
NO (1) NO322254B1 (en)
NZ (1) NZ305188A (en)
PL (1) PL184022B1 (en)
PT (1) PT817851E (en)
SK (1) SK284281B6 (en)
WO (1) WO1996029413A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
ZA982950B (en) 1997-04-08 1998-10-19 Merck & Co Inc Stabilized human papillomavirus formulations
CN1259051A (en) * 1997-04-08 2000-07-05 麦克公司 Stabilized human papillomavirus formulations
CN1354787A (en) * 1998-08-14 2002-06-19 麦克公司 Process for purifying human papillomavirus virus-like particles
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
SI1150712T1 (en) 1999-02-05 2009-02-28 Merck & Co Inc Human papilloma virus vaccine formulations
FR2795074A1 (en) * 1999-05-21 2000-12-22 Inst Nat Sante Rech Med POLYPEPTIDES TRANSPORTING AMINO ACIDS, IN PARTICULAR GLUTAMATE, AND METHODS OF SCREENING INHIBITOR OR ACTIVATOR COMPOUNDS OF TRANSPORT ACTIVITY
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
TWI457133B (en) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa Novel composition
DK2154147T3 (en) 2007-04-29 2015-12-07 Beijing Wantai Biological Pharmacy Entpr Co Ltd Truncated L1 protein of human papillomavirus 16
US9364529B2 (en) 2007-04-29 2016-06-14 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Truncated L1 protein of human papillomavirus type 18
CN101440373B (en) * 2007-11-23 2012-09-05 上海泽润生物科技有限公司 Truncated 18 type human papilloma virus major capsid protein L1 gene
AU2010264695A1 (en) * 2009-06-25 2012-01-19 Glaxosmithkline Biologicals S.A. Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease
CA2839427C (en) * 2011-06-15 2016-09-27 Chung-Ang University Industry-Academic Cooperation Foundation Method for enhancing the production yield of human papillomavirus l1 protein
CA2866582A1 (en) 2012-03-18 2013-09-26 Brigitte Desiree Alberte Colau Method of vaccination against human papillomavirus
CN108276491B (en) * 2018-02-05 2021-01-12 南京薇熙生物医药科技有限公司 Monoclonal antibody capable of specifically recognizing HPV18L1 protein and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625257A1 (en) * 1986-07-23 1988-02-04 Behringwerke Ag EXPRESSION PRODUCTS OF THE HUMAN PAPILLOMVIRUS TYPE 16 AND 18, FOR THESE PROTEINS, SPECIFIC ANTIBODIES AND THESE ANTIBODIES OR. CORRESPONDING DNA-CONTAINING DIAGNOSTICS
DE4015044A1 (en) * 1990-05-10 1991-11-14 Behringwerke Ag SEROREACTIVE EPITOPE ON PROTEINS OF THE HUMAN PAPILLOMAVIRUS (HPV) 18
SG48769A1 (en) * 1991-07-19 1998-05-18 Univ Queensland Papilloma virus vaccine
PT647140E (en) * 1992-06-25 2007-12-27 Univ Georgetown Papillomavirus vaccines
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
AU688759C (en) * 1993-03-09 2006-12-21 University Of Rochester Production of human papillomavirus capsid protein and virus-like particles

Also Published As

Publication number Publication date
EP1422294A1 (en) 2004-05-26
PT817851E (en) 2004-06-30
EP0817851B1 (en) 2004-02-18
DE69631586T9 (en) 2005-06-16
IL117459A (en) 2005-11-20
CZ293697A3 (en) 1998-02-18
CA2215834A1 (en) 1996-09-26
PL322333A1 (en) 1998-01-19
AU5314196A (en) 1996-10-08
ES2213772T3 (en) 2004-09-01
AU714533B2 (en) 2000-01-06
SK127897A3 (en) 1998-07-08
MX9707208A (en) 1997-11-29
DE122007000030I1 (en) 2007-07-19
HUP9801334A2 (en) 1998-08-28
NO322254B1 (en) 2006-09-04
DK0817851T3 (en) 2004-08-16
JPH11502704A (en) 1999-03-09
WO1996029413A3 (en) 1996-11-28
HUP9801334A3 (en) 1999-04-28
DE122007000031I1 (en) 2007-07-19
EP0817851B9 (en) 2004-08-18
NO974322L (en) 1997-11-24
DK0817851T5 (en) 2004-10-25
EP0817851A2 (en) 1998-01-14
PL184022B1 (en) 2002-08-30
WO1996029413A2 (en) 1996-09-26
IL117459A0 (en) 1996-07-23
HU223761B1 (en) 2005-01-28
NL300271I1 (en) 2007-05-01
CN1185176A (en) 1998-06-17
NO974322D0 (en) 1997-09-19
NL300272I1 (en) 2007-05-01
DE69631586D1 (en) 2004-03-25
DE69631586T2 (en) 2005-01-27
EA001092B1 (en) 2000-10-30
KR100430698B1 (en) 2004-07-15
CA2215834C (en) 2007-06-12
EA199700256A1 (en) 1999-06-24
ATE259879T1 (en) 2004-03-15
NL300273I1 (en) 2007-05-01
FR07C0023I1 (en) 2007-04-27
NZ305188A (en) 1999-11-29
DE122007000025I1 (en) 2007-07-12
CZ291242B6 (en) 2003-01-15
CN1100876C (en) 2003-02-05
SK284281B6 (en) 2004-12-01

Similar Documents

Publication Publication Date Title
FR07C0023I2 (en) DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18
DE69634533D1 (en) disposable
FI971176A (en) DNA photo-cleavage by texapyrins
TR199700447A3 (en) "Polymerization catalyst"
FI963201A (en) Antiparasitic substances
DK0810877T3 (en) Hepatitis B vaccine
FI98872B (en) Improved step-adjustable filter
ZA962245B (en) Dna encoding human papillomavirus type 18
DE69622331D1 (en) Blender
PT1019358E (en) 3,3-DIARILPROPILLAMINES ITS USE AND PREPARATION
NO964628D0 (en) DNA sequences
PL319294A1 (en) Dna encoding the human papilloma virus of 6 a type
DE69509766D1 (en) MICROEMULSIONS
DE69612897D1 (en) Micro file
DE69737803D1 (en) baker's yeast
IT1276074B1 (en) DISPOSABLE RECTOSCOPE
DE69606985D1 (en) IMPROVED POTENTIOMETER
DE69730411D1 (en) METASTASES INDUCING DNA'S
KR960028201U (en) Improved mat
FR2732339B1 (en) NOVEL PHOTO-INDUCTION DNA CLAVING AGENTS
KR970005245A (en) Articulator
KR970009717U (en) Catalyst Cleaner
BR7501397U (en) Disposable mat
KR960032378U (en) V's Knob Structure
KR970012807U (en) Driver's chair